Home/Filings/4/0000899243-22-012786
4//SEC Filing

Giffin Brett A. 4

Accession 0000899243-22-012786

CIK 0001492674other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 4:05 PM ET

Size

5.4 KB

Accession

0000899243-22-012786

Insider Transaction Report

Form 4
Period: 2022-02-26
Giffin Brett A.
Chief Commercial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-02-26+500,000500,000 total
    Common Stock (500,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units vest in three equal annual installments on November 8, 2022, November 8, 2023, and October 1, 2024.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001892921

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:05 PM ET
Size
5.4 KB